Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-04-009807
Filing Date
2004-08-16
Accepted
2004-08-16 16:20:37
Documents
5
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y00602e10vq.txt 10-Q 141875
2 CERTIFICATION y00602exv31w1.txt EX-31.1 3536
3 CERTIFICATION y00602exv31w2.txt EX-31.2 3474
4 CERTIFICATION y00602exv32w1.txt EX-32.1 1364
5 CERTIFICATION y00602exv32w2.txt EX-32.2 1400
  Complete submission text file 0000950123-04-009807.txt   153748
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 04978983
SIC: 2835 In Vitro & In Vivo Diagnostic Substances